Hydroxychloroquine – New Evidence for Better Pregnancy Outcomes in APS
Aya Berman, Family medicine resident at Clalit Health Services, shared a post on LinkedIn:
“Thrilled to share our new study: ‘Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis” is now published in RMD Open.
This study represents a meaningful step in understanding the role of hydroxychloroquine in improving obstetric outcomes for patients with antiphospholipid syndrome.
The findings were first presented by Dr. Orly Efros at the International Society on Thrombosis and Haemostasis (ISTH) Annual Congress in Bangkok, and I am delighted that the full manuscript is now available here.
Grateful to my colleagues and collaborators for their dedication and contributions that made this work possible!
Orly Efros, Gili Kenet, Aharon lubetsky, Nancy Agmon-Levin, Shelly Soffer, MD, assaf barg, Sarina Levy mendelovich, omri cohen, Liat Waldman Radinsky, Shadan Lalezari, Eyal Klang”

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026